Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1017 - 1024 of 12065 results

New Legislative Session, New Attempts at Banning Non-Competes in New York (City)
March 13, 2024| Blog| Viewpoint

Why The SEC Climate Rule Might Not Standardize Emissions Reporting
March 13, 2024| News

FDA Needs a New Approach to AI/ML-Enabled Medical Devices
March 12, 2024| Blog| Viewpoint

Compliance with the New York LLC Transparency Act Necessary for Many Mintz Clients
March 12, 2024| Alert| Viewpoint

Former Lab Owners, Compliance Officer Face Prison Time Over False Claims
March 12, 2024| News

Side Letter: CalPERS' Co-invest Conviction
March 12, 2024| News

New Mexico’s Health Care Consolidation Oversight Act: An Overview
March 11, 2024| Blog| Viewpoint
News & Press Releases
Mintz Advises PHLUR on Acquisition by TSG Consumer
July 29, 2025
Mintz advised PHLUR, a modern fragrance brand recognized for its emotion-led storytelling and accessible positioning, in its acquisition by TSG Consumer, a leading private equity firm specializing in consumer brands.
Mintz Attorneys Named to Los Angeles Business Journal’s 2025 “Leaders of Influence: Litigators & Trial Attorneys” List
July 28, 2025
Mintz Member Esteban Moralesand Special Counsel Nada Shamonki has been recognized by Los Angeles Business Journal in its 2025 “Leaders of Influence: Litigators & Trial Attorneys” list which recognizes lawyers who “go to the proverbial mat to fight for their clients,” according to the publication.
Is Biopharma M&A In a Holding Pattern or a ‘New Normal’
July 23, 2025
Life Sciences International Chair Cheryl Reicin recently joined the Scrip M&A Podcast to share insights on the evolving landscape of biopharmaceutical mergers and acquisitions. In the episode, Cheryl highlights an uptick in pre-M&A activity, as major pharmaceutical companies increasingly leverage license and option agreements to strengthen their pipelines and product portfolios while positioning themselves for potential future acquisitions.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
